Health ProductsAdvisory

Archive - Health Canada warns consumers not to use Nasutra due to potential health risks

· Published by Health Canada · Official notice

Details

Alert type: Advisory
Category: Natural health products
Issue: Undeclared Substance, Unauthorized products
Audience: General Public
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Images

Details

Health Canada is warning consumers not to use the product Nasutra because it has been found to contain the undeclared ingredient sildenafil (chemical name for ViagraTM) that could lead to serious health risks, especially for patients with existing medical conditions such as heart problems, those who may be taking heart medications, or those who may be at risk for strokes.

Nasutra is advertised as an all-natural traditional Chinese medicine for sexual enhancement, but it was found to contain sildenafil, which should only be used under medical supervision. Sildenafil has also been associated with serious side-effects including sudden vision loss, penile tissue damage and urinary tract infection.

This product is not authorized for sale in Canada, but it may be available to Canadian consumers through the Internet, personal importation, or other venues. Canadians who may have purchased Nasutra over the Internet or while travelling abroad are warned not to use it, and to consult with a health care professional if they have concerns about their health due to this product.

Nasutra has been found for sale in New Zealand. As a result, the New Zealand Medicines and Medical Devices Safety Authority tested the product and issued a warning advising the public not to purchase or consume the product Nasutra.

Health Canada also advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find Nasutra products in Canada. Health Canada has notified the Canada Border Services Agency to detain any shipment of Nasutra at the border.

To report a suspected adverse reaction with these or any other health product, please contact the Canadian Adverse Drug Reaction Monitoring Program (CADRMP) of Health Canada by one of the following methods:

Telephone: 866-234-2345
Facsimile: 866-678-6789

CADRMP
Marketed Health Products Directorate
Health Protection Building, Tunney's Pasture, AL 0701C
Ottawa, Ontario K1A 0K9

Email: cadrmp@hc-sc.gc.ca

Consumers requiring more information about this advisory can contact Health Canada's public enquiries line at (613) 957-2991, or toll free at 1-866-225-0709.

Media enquiries

Health Canada
(613) 957-2983

Public enquiries

(613) 957-2991
1(866) 225-0709
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime